Allergy Vaccine Passes Phase II Clinical Trial

(Medical News Today) UPDATED 2011-10-05

A Phase II clinical trial suggests that the ToleroMune hay fever vaccine improves allergy symptoms better than a placebo. The trial found that a regimen of the vaccine improved eye allergy reactions by 30 percent and skin reactions by 54 percent. The final phase II trial is currently underway in Canada. Read full story >

See all Allergy News

This helped!

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

We comply with the HONcode standard for
trustworthy health information: verify here.

By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.

Healthcentral.com is part of Remedy Health Media

Allergy Vaccine Passes Phase II Clinical Trial

People who read this also read...

What the community is saying...

Q & A on Drug Reactions: Was it an Allergic or Non-Allergic Type of Reaction?

James Thompson, MD